All In Biotech

Drug Trial Radar · NCT07598734

Doxepin Alone or Combined With Ramelteon Versus Placebo for Improving Sleep Quality After Primary Total Knee Arthroplasty

Doxepin Versus Doxepin and Ramelteon Versus Placebo to Improve Sleep Quality After Primary Total Knee Arthroplasty: A Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: May 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 129 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

129

Planned (sponsor's estimate)

Start

Jun 2026

Primary completion

Jun 2028

Study completion Jun 2028

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Supportive care
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Many patients experience poor sleep during recovery after total knee arthroplasty (TKA). Disturbed sleep can last weeks to months and may worsen pain, slow healing, and reduce overall quality of life. Few safe, effective, evidence-based options exist to improve sleep during this recovery period. This study aims to determine whether the medications doxepin, either alone or in combination with ramelteon, can improve sleep quality during early recovery after TKA. The investigators will also evaluate whether improved sleep leads to better pain control, knee function, and overall quality of life.

Conditions

  • Sleep Quality Post-TKA
  • Postoperative Knee Function
  • Quality of Life After Primary TKA

Interventions

  • Doxepin 6 mgDrug

    Doxepin 6 mg administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty

  • Ramelteon 8 mgDrug

    Ramelteon 8 mg administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty

  • Placebo TabletsDrug

    Placebo administered orally once nightly for sleep during the first 6 weeks of the postoperative period following total knee arthroplasty

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Insomnia Severity Index (ISI) scores (sleep quality)Time frame: Baseline; 2 weeks postoperatively; 6 weeks postoperatively; 3 months postoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Washington Medical Center Hip & Knee Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.